Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator-activated receptor gamma-dependent pathway
✍ Scribed by Matthew Milkevitch; Nancy J. Beardsley; E. James Delikatny
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 181 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0952-3480
- DOI
- 10.1002/nbm.1484
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The effects of the selective peroxisome proliferator activated receptor‐gamma (PPAR‐γ) inhibitor GW9662 on phenylbutyrate (PB)‐induced NMR‐detectable lipid metabolites was investigated on DU145 prostate cancer cells. DU145 cells were perfused with 10 mM PB in the presence or absence of 1 µM of GW9662 and the results monitored by ^31^P and diffusion‐weighted ^1^H NMR spectroscopy. GW9662 completely reversed PB‐induced NMR‐visible lipid and total choline accumulation in ^1^H spectra and glycerophosphocholine and β‐NTP in ^31^P spectra. In addition, pre‐incubation with GW9662 significantly reduced PB‐induced caspase‐3 activation, reversed the G~1~ block as measured by flow cytometry, and otherwise had little effect on cell survival as measured by MTT assay. These results suggest that the NMR visible lipid accumulation and apoptosis induced by PB treatment occurs through a mechanism that is mediated by PPAR‐γ. Copyright © 2010 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Peroxisome proliferator‐activated receptor gamma (PPARγ) inhibits cell growth __via__ promoting apoptosis. Human colorectal cancer tissues had abundant PPARγ but the incidence of apoptosis was very low, suggesting a defect in the PPARγ pathway. Here, we found that 15‐hydroxy‐eicosatetra